FTY720 reduces inflammation and promotes functional recovery after spinal cord injury

Journal of Neurotrauma

Volumn 26, Issue 12, 2009, Pages 2335-2344

  Lee, Kangmin D ^a   Chow, Woon N ^b   Sato Bigbee, Carmen ^b   Graf, Martin R ^a   Graham, Robert S ^a   Colello, Raymond J ^b   Young, Harold F ^a   Mathern, Bruce E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Behavioral assessment; FTY720; Inflammation; Locomotor function; Spinal cord injury

Indexed keywords

FINGOLIMOD;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECT; DRUG EFFICACY; FUNCTIONAL ASSESSMENT; HEMORRHAGIC CYSTITIS; LONG EVANS RAT; LYMPHOCYTIC INFILTRATION; MYELITIS; NEUROPROTECTION; NONHUMAN; RAT; SPINAL CORD INJURY; T LYMPHOCYTE; WHITE MATTER;

ANIMALS; AUTOIMMUNITY; CHEMOTAXIS, LEUKOCYTE; DEMYELINATING AUTOIMMUNE DISEASES, CNS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MYELITIS; NERVE FIBERS, MYELINATED; NERVE REGENERATION; PARALYSIS; PROPYLENE GLYCOLS; RATS; RATS, LONG-EVANS; RECOVERY OF FUNCTION; SPHINGOSINE; SPINAL CORD INJURIES; T-LYMPHOCYTES; TREATMENT OUTCOME; URINARY BLADDER, NEUROGENIC; WALLERIAN DEGENERATION;

EID: 75449116198     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2008.0840     Document Type: Article

References (49)

1. Ankeny, D., Lucin, K., Sanders, V., McGaughy, V., and Popovich, P. (2006). Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis. J. Neurochem. 99, 1073-1087.
2. Apodaca, G., Kiss, S., Ruiz, W., Meyers, S., Zeider, M., and Birder, L. (2003). Disruption of bladder epithelium barrier function after spinal cord injury. Am. J. Physiol. Renal Physiol. 284, 966-976.
3. Banati, R.B., and Graeber, M.B. (1994). Surveillance, intervention and cytotoxicity: is there a protective role of microglia? Dev. Neurosci. 16, 114-127.
4. Bao, F., and Liu, D. (2002). Peroxynitrite generated in the rat spinal cord induces neuron death and neurological deficits. Neuroscience 115, 839-849.
5. Basso, D.M., Beattie, M.S., and Bresnahan, J.C. (1995). A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1-21.
6. Beril, G., Solaroglu, I., Okutan, O., Cimen, B., Kaptanoglu, E., and Palaoglu, S. (2007). Metoprolol treatment decreases tissue myeloperoxidase activity after spinal cord injury in rats. J. Clin. Neurosci. 14, 138-142.
7. Blight, A. (1994). Effects of silica on the outcome from experimental spinal cord injury: implication of macrophages in secondary tissue damage. Neuroscience 60, 263-273.
8. Bohler, T., Waiser, J., Schuetz, M., Neumayer, H., and Budde, K. (2004). FTY720 exerts differential effects on CD4+ and CD8+ T-lymphocyte subpopulations expressing chemokine and adhesion receptors. Nephrol. Dial. Transplant. 19, 702-713.
9. Brinkman, V., Cyster, J.G., Hla, T. (2004). FTY720: Sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am. J. Transplant 4, 1019-1025.
10. Brinkmann, V., Davis, M., Heise, C., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., Foster, C., Zollinger, M., and Lynch, K. (2002). The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277, 21453-21457.
11. Brinkmann, V., Pinschewer, D., Chiba, K., and Feng, L. (2000). FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation. Trends Pharmacol. Sci. 21, 49-52.
12. Budde, K., Schmouder, R., Nashan, B., Brunhorst, R., Lucker, P., Mayer, T., Brookman, L., Nedelman, J., Skerjanec, A., Bohler, T., and Neumayer, H. (2003). Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients. Am. J. Transplant. 3, 836-854.
13. Chao, C., Hu, S., Molitor, T., Shaskan, E., and Peterson, P. (1992). Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Neuroimmunol. 149, 2736-2741.
14. Chiba, K., Tanagawa, Y., Masubuchi, Y. Kataoka, H., Kawaguchi, T., Ohtsuki, M., and Hoshino, Y. (1998). FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J. Immunol. 160, 5037-5044. (Pubitemid 28215340)
15. Coelho, R., Payne, S., Bittman, R., Spiegel, S., and Sato-Bigbee, C. (2007). The immunomodulator FTY720 has a direct cytoprotective effect on oligodendrocyte progenitors. J. Pharmacol. Exp. Ther. 323, 626-635.
16. Doggweiler, D., Jasmin, L., and Schmidt, R. (1998). Neurogenically mediated cystitis in rats: An animal model. J. Urol. 160, 1551-1556.
17. Donnelly, D.J., and Popovich, P.G. (2008). Inflammation and its role in neuroprotection, axonal regeneration, and functional recovery after spinal cord injury. Exp. Neurol. 209, 378-388.
18. Fujino, M., Funeshima, N., Kitazawa, Y., Kimura, H., Amemiya, H., Suzuki, S., and Li, X. (2003). Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment. J. Pharmacol. Exp. Ther. 305, 70-77.
19. Giulian, D., and Robertson, C. (1990). Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann. Neurol. 27, 33-42.
20. Gonzalez, R., Glaser, J., Liu, M., Lane, T., and Keirstead, H. (2003). Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury. Exp. Neurol. 184, 456-463.
21. Graf, M., Prins, R., and Merchant, R. (2001). IL-6 secretion by a rat T9 glioma clone induces a neutrophil-dependent antitumor response with resultant cellular, antiglioma immunity. J. Immunol. 166, 121-129.
22. Gris, D., Marsh, D., Oatway, M., Chen, Y., Hamilton, E., Dekaban, G., and Weaver, L. (2004). Transient blockade of the CD11d=CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J. Neurosci. 24, 4043-4051.
23. Hauben, E., Agranov, E., Gothilf, A., Nevo, U., Cohen, A., Smirnov, I., Steinman, L., and Schwartz, M. (2001). Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease. J. Clin. Invest. 108, 591-599.
24. Hauben, E., Butovsky, O., Nevo, U., Yoles, E., Moalem, G., Agranov, E., Mor, F., Leibowitz-Amit, R., Pevsner, E., Akselrod, S., Neeman, M., Cohen, I., and Schwartz, M. (2000). Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J. Neurosci. 20, 6421-6430.
25. Ibarra A., Correa D., Willms K., Merchant M.T., Guizar-Sahagú n, G., Grijalva, I., and Madrazo, I. (2003). Effects of cyclosporin-A on immune response, tissue protection, and motor function of rats subjected to spinal cord injury. Brain Res. 979, 165-178.
26. Jones, T., Ankeny, D., Guan, Z., McGaughy, V., Fisher, L., Basso, M., and Popovich, P. (2004). Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. J. Neurosci. 24, 3752-3761.
27. Jones, T., Basso, M., Sodhi, A., Pan, J., Hart, R., MacCallum, R., Lee, S., Whitacre, C., and Popvich, P. (2002). Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: Implications for autoimmune vaccine therapy. J. Neurosci. 22, 2690-2700.
28. Kahan, B., Karlix, J., Feruson, R., Leichtman, A., Mulgaonkar, S., Gonwa, T., Skerjanec, A., Schmouder, R., and Chodoff, L. (2003). Pharmacodynamics, pharmacokinetics and safety of multiple doses of FTY720 in stable renal transplant patients: A multicenter, randomized, placebo-controlled, phase I study. Transplantation 76, 1079-1084.
29. Kreutzberg, G.W. (1996). Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318.
30. Lee, M., Thangada, S., Claffey, K., Ancellin, N., Liu, C., Kluk, M., Volpi, M., Sha'afi, R., and Hla, T. (1999). Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99, 301-312.
31. Leung, P., Johnson, C., and Wrathall, J. (2007). Comparison of the effects of complete and incomplete spinal cord injury on lower urinary tract function as evaluated in unanesthetized rats. Exp. Neurol. 208, 80-91.
32. Lipton, H., Kalio, P., and Jelachich, M. (2005). Simplified quantitative analysis of spinal cord cells from Theiler's virusinfected mice without the requirement for myelin debris removal. J. Immunol. Meth. 299, 107-115.
33. Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G., Card, D., Keohane, C., Rosenbach, M., Hale, J., Lynch, C., Rupprecht, K., Parsons, W., and Rosen, H. (2002). Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296, 346-349.
34. Matloubian, M., Lo, C., Cinamon, G., Lesneski, M., Xu, Y., Brinkmann, V., Allende, M., Proia, R., and Cyster, J. (2004). Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427, 355-360.
35. Pannu, R., Barbosa, E., Singh, A., and Singh, I. (2005). Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. J. Neurosci. Res. 79, 340-350.
36. Pinschewer, D.O., Ochsenbein, A.F., Odermatt, B., Brinkmann, V., Hengartner, H., and Zinkernagel, R.M. (2000). FTY720 immunosuppression impairs effector T-cell peripheral homing without affecting induction, expansion, and memory. J. Immunol. 164, 5761-5770.
37. Popovich, P., and Jones, T. (2003). Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol. Sci. 24, 13-17.
38. Popovich, P., Guan, Z., Wei, P., Huitinga, I., Van Rooijen, N., and Stokes, B. (1999). Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 158, 351-365.
39. Popovich, P., Stokes, B., and Whitacre, C. (1996). Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system. J. Neurosci. Res. 45, 349-363.
40. Potas, J., Zheng, Y., Moussa, C., Venn,M., Gorrie, C., Deng, C., and Waite, P. (2006). Augmented locomotor recovery after spinal cord injury in the athymic nude rat. J. Neurotrauma 23, 660-673.
41. Quesniaux, V., Fullard, L., Arendse, H., Davison, G., Markgraaff, N., Auer, R., Ehrhart, F., Kraus, G., and Schuurman, H. (1999). A novel immunosuppressant, FTY720 induces peripheral lymphodepletion of both T- and B-cells and immunosuppression in baboons. Transpl. Immunol. 7, 149-157.
42. Rimaniol, A., Haik, S., Martin, M., Le Grand, R., Boussin, F., Dereuddre-Bosquet, N., Gras, G., and Dormont, D. (2000). Na+-dependent high-affinity glutamate transport in macrophages. J. Immunol. 164, 5430-5438.
43. Schwartz, M., and Kipnis, J. (2002). Multiple sclerosis as a byproduct of the failure to sustain protective autoimmunity: a paradigm shift. Neuroscientist 8, 405-413.
44. Schwartz, M., and Kipnis, J. (2001). Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries. Trends Mol. Med. 7, 252-258.
45. Schwartz, M. (2001). Harnessing the immune system for neuroprotection: therapeutic vaccines for acute and chronic neurodegenerative disorders. Cell. Mol. Neurobiol. 21, 617-627.
46. Shamash, S., Reichert, F., and Rotshenker, S. (2002). The cytokine network of wallerian degeneration: tumor necrosis factoralpha, interleukin-1 alpha, and interleukin-1beta. J. Neuosci. 22, 3052-3060.
47. Waterson, K., Berg, K., Kapitonov, D., Payne, S., Miner, A., Bittman, R.,Milstien, S., Ratz, P., and Spiegel, S. (2007). Sphingosine-1-phosphate and the immunosuppressant, FTY720-phosphate, regulate detrusor muscle tone. FASEB J. 21, 2818-2828.
48. Yin, Y., Henzl, M., Lorber, B., Nakazawa, T., Thomas, T., Jiang, F., Langer, R., and Benowitz, L. (2006). Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat. Neurosci. 9, 843-852.
49. Yoles, E., Hauben, E., Palgi, O., Agranov, E., Gothilf, A., Cohen, A., Kuchroo, V., Cohen, I. R., Weiner, H. and Schwartz, M. (2001). Protective autoimmunity is a physiological response to CNS trauma. J. Neurosci. 21, 3740-3748. (Pubitemid 32466465)